KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Net Margin (2016 - 2026)

Medpace Holdings filings provide 12 years of Net Margin readings, the most recent being 17.53% for Q1 2026.

  • On a quarterly basis, Net Margin fell 299.0% to 17.53% in Q1 2026 year-over-year; TTM through Mar 2026 was 17.19%, a 212.0% decrease, with the full-year FY2025 number at 17.83%, down 134.0% from a year prior.
  • Net Margin hit 17.53% in Q1 2026 for Medpace Holdings, down from 19.07% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 21.81% in Q4 2024 to a low of 13.25% in Q2 2023.
  • Median Net Margin over the past 5 years was 17.21% (2022), compared with a mean of 17.23%.
  • Biggest five-year swings in Net Margin: skyrocketed 610bps in 2024 and later tumbled -299bps in 2026.
  • Medpace Holdings' Net Margin stood at 17.42% in 2022, then decreased by -10bps to 15.71% in 2023, then surged by 39bps to 21.81% in 2024, then fell by -13bps to 19.07% in 2025, then decreased by -8bps to 17.53% in 2026.
  • The last three reported values for Net Margin were 17.53% (Q1 2026), 19.07% (Q4 2025), and 16.84% (Q3 2025) per Business Quant data.